Uther
Finnrick has tested 72 samples from Uther across 13 products.
Finnrick Vendor Profile
to
Uther
Tracking 13 products
72 total samples tested
Last test 20 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Mazdutide | 2 | 9 Oct 2025 | 9 Oct 2025 | |||||
| Melanotan II | 2 | 9 Oct 2025 | 9 Oct 2025 | |||||
| PT-141 | 2 | 9 Oct 2025 | 9 Oct 2025 | |||||
| Semaglutide | 3 | 9 Oct 2025 | 29 Dec 2025 | |||||
| Tesamorelin | 5 | 24 Jul 2025 | 20 Mar 2026 | |||||
| BPC-157 | 10 | 3 Jul 2025 | 2 Mar 2026 | |||||
| GHK-Cu | 6 | 9 Oct 2025 | 4 Mar 2026 | |||||
| Retatrutide | 13 | 3 Jul 2025 | 4 Mar 2026 | |||||
| Tirzepatide | 13 | 3 Jul 2025 | 6 Jan 2026 | |||||
| Cagrilintide | 3 | 9 Oct 2025 | 13 Mar 2026 | |||||
| Ipamorelin | 5 | 9 Oct 2025 | 10 Feb 2026 | |||||
| Survodutide | 3 | 9 Oct 2025 | 23 Oct 2025 | |||||
| CJC-1295 | 5 | 9 Oct 2025 | 7 Mar 2026 | |||||
Some samples were submitted by Uther as part of the Launch with Finnrick vendor support program. Samples are otherwise either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.7
Based on 15 overall satisfaction reports
Ease of Purchase4.7(15)
Payment Methods4.5(15)
Delivery Speed4.6(15)
Packaging Quality4.3(15)
Customer Service4.7(15)
People who submitted test requests to Finnrick gave Uther an average satisfaction rating of 4.7 out of 5 across 15 reports associated with samples received and tested by Finnrick.
Most recent Uther tests
Samples are tested in commercial labs
72
tests
13
products
Scores
AVGMINMAX
First
3 Jul 2025
Last
20 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Variant | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 Mar 2026 | Tesamorelin | View | 20mg | 23.7mg | +18.5% | 99.80% | TE20-0303 | No Label / Blue Crimp / Green Cap | Lab G | Public | ||
| 13 Mar 2026 | Cagrilintide | View | 5mg | 3.7mg | -26.0% | 99.20% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | ||
| 7 Mar 2026 | CJC-1295 | View | NO DAC | 10mg | 9.6mg | -4.0% | 99.90% | CJND10-0113 | Silver Label / Black Crimp / Clear Red Cap | Lab G | Public | |
| 4 Mar 2026 | Retatrutide | View | 10mg | 10mg | 99.60% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |||
| 4 Mar 2026 | Retatrutide | View | 5mg | 5.2mg | +4.0% | 99.20% | (no batch ID) | No Label / Silver Crimp / Clear Cap | Lab G | Public | ||
| 4 Mar 2026 | GHK-Cu | View | 50mg | 27.7mg | -44.6% | 99.70% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | ||
| 2 Mar 2026 | BPC-157 | View | 5mg | 4.22mg | -15.6% | 99.90% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | ||